The biology behind the risk is unforgiving. Ultraviolet radiation inflicts structural damage on DNA in skin cells, and while the body’s antioxidant repair mechanisms normally cope, saturation of those systems tips the balance toward carcinogenesis. Chronic exposure also degrades skin structure, suppresses immune defenses in the skin, and damages the eyes, contributing to cataracts, keratitis, and pterygium. At altitude the danger is amplified because UV radiation travels a shorter distance through the atmosphere before striking the skin. Peru’s national weather service classifies UV levels across much of the Andean region as extremely high, and the country’s Ministry of Health recorded 3,525 cases of skin cancer between 2021 and 2023. Malignant melanoma, the most aggressive form of the disease, is the third most common cancer among Peruvians aged fifteen to thirty-nine, yet an estimated nine in ten cases are attributable to UV exposure, which makes it one of the most preventable cancers anywhere.

What makes the Andean situation distinctive is that sun exposure is not a seasonal or recreational hazard but a constant of daily life. Outdoor agricultural work, walking to school, and everyday recreation all unfold under a relentless sun, and in many rural communities this exposure is so normalized that it is not perceived as a health risk at all. Adolescents are particularly exposed through school activities and farm labor, while often lacking access to health information and services. Previous photoprotection studies in Peru and across Latin America have focused mostly on urban or peri-urban primary school children, leaving rural high-altitude adolescents, the group facing the highest cumulative UV loads, largely unstudied.

The research team, led by Yadhira Grecia Otazu Masco, Lizbeth Huarilloclla Ramos, and Lucy Puno-Quispe, worked with thirty-seven students aged thirteen to seventeen at a public rural school. With only two intact third-year sections available, one classroom of eighteen students served as the control group and the other, nineteen students, received the intervention. The design was quasi-experimental: both groups completed identical assessments before and after the two-month program, and the researchers used analysis of covariance to statistically adjust for any baseline differences between the groups. Notably, no students dropped out or were excluded, so the final sample matched the full enrolled cohort.

The INTI program itself was built for the classroom rather than the clinic. It consisted of twelve in-person sessions of forty-five minutes each, delivered twice weekly over two months, a duration chosen because habit-formation research suggests healthy behaviors typically need two to five months to consolidate. The sessions progressed from the biology of sun exposure and skin phototypes through sunburn, protective practices, sunscreen use, the emotional dimensions of skin health, the value of early prevention, nutrition and hydration, and even the legislation surrounding sun protection. Each session followed the ARDE methodology, a four-stage pedagogical structure of animation, reflection, demonstration, and evaluation, which pushed students beyond passive listening into repeated hands-on practice.

Measurement relied on the CHACES questionnaire, a validated Spanish-language instrument covering sun-exposure habits, attitudes, and knowledge of sunburn prevention. The team first checked content validity with a panel of seven expert judges, five physicians and two community health nurses, yielding an Aiken’s V coefficient of 0.91, then pilot-tested the instrument with fifteen comparable secondary students, producing a preliminary Cronbach’s alpha of 0.73. Baseline testing confirmed the two classrooms started on equal footing, with no statistically significant pretest differences in knowledge, habits, or attitudes.

The posttest results showed a consistent advantage for the INTI group across all three dimensions. After adjusting for baseline scores, the intervention group scored significantly higher on knowledge (F = 4.93, p = 0.033), habits (F = 20.3, p < 0.001), and attitudes (F = 6.03, p = 0.019). The largest effect, by a wide margin, appeared in habits, which accounted for roughly thirty-seven percent of the variance in posttest scores, a substantial effect size for an educational intervention. The pattern behind this number is revealing: the control group’s habit scores actually declined from pretest to posttest while the experimental group’s rose, and that divergence, rather than a mere difference in improvement rates, drove the adjusted difference. Attitudes barely moved in the control group, suggesting this dimension may resist change without direct intervention, while knowledge improved in both classrooms, hinting that some informational gains may occur regardless of a formal program.

The researchers attribute the outsized habit effect to the structure of INTI itself. Because several sessions were organized around repeated practice and demonstration, drawing on the reflection and demonstration stages of the ARDE methodology, the program may have engaged the behavioral machinery of habit formation more directly than purely cognitive lessons could. This interpretation aligns with a broader literature: a multicomponent sun-safety intervention with 106 middle schoolers improved knowledge and attitudes, and systematic reviews of school-based photoprotection programs across childhood and adolescence consistently report gains in both knowledge and protective behavior. The Andean results also contrast sharply with findings among adult agricultural workers, many of whom remained unaware of the risks of prolonged exposure and reluctant to use sunscreen, suggesting that reaching people before adulthood, when habits are still plastic, may be the decisive window.

The study’s context matters as much as its statistics. Earlier work has shown that parental knowledge of photoprotection predicts children’s protective practices, and that parent-targeted education can improve children’s sun behaviors, pointing toward a natural extension of INTI that brings caregivers into the program. Gender differences in photoprotection habits documented elsewhere also argue for tailored content. And while digital tools such as a facial-aging web application have produced sustained behavior change over three-month follow-ups, follow-up duration alone does not reliably predict lasting protection; poverty and limited access to health services, both prevalent in rural Puno, shape whether protective habits take root at all.

The authors are appropriately candid about the limits of their evidence. Randomization occurred at the classroom level with only one classroom per condition, so group membership is confounded with classroom membership and the independence of individual observations may not hold. Convenience sampling, the small sample of thirty-seven, and the absence of data on family influence, economic constraints, or cultural norms all restrict generalizability, and the self-reported outcomes were captured at a single posttest point, leaving open whether the changes persist. Still, as preliminary evidence, the study makes a compelling case for embedding photoprotection education in rural school curricula, training teachers and health staff, and ensuring access to UV protection products in regions where the sun is an inescapable fact of geography. For the teenagers of the high Andes, whose skin absorbs a lifetime of ultraviolet damage before they finish secondary school, twelve structured classroom sessions may prove one of the cheapest and most effective cancer-prevention tools available.

Subject of Research: Effectiveness of a school-based photoprotection education program among adolescents in a high-altitude rural Andean region

Article Title: Effectiveness of INTI educational program on photoprotection among adolescents in high-altitude rural Andean school: A quasi-experimental study

Article References: Otazu Masco, Y. G., Huarilloclla Ramos, L., & Puño-Quispe, L. (2026). Effectiveness of INTI educational program on photoprotection among adolescents in high-altitude rural Andean school: A quasi-experimental study. Public Health in Practice, 12, Article 100853. https://doi.org/10.1016/j.puhip.2026.100853

Image Credits: AI Generated

DOI: 10.1016/j.puhip.2026.100853

Keywords: photoprotection, UV radiation, skin cancer, adolescents, Andes, Peru, sun safety education, quasi-experimental study, public health, melanoma prevention, school health program, high altitude

Tyrosinase sits at the heart of the pigmentation pathway. Human skin color is determined largely by melanin, which exists in two forms: dark eumelanin and reddish pheomelanin. Both absorb ultraviolet radiation and protect the skin from environmental damage, but excessive pigment deposition drives a range of disorders including chloasma, freckles, acanthosis nigricans, Riehl’s melanosis, skin aging and, in severe cases, melanoma. Because tyrosinase is the rate-limiting enzyme in the double-loop oxidation process that converts L-tyrosine into dopachrome, the precursor of melanin, it has long been the primary therapeutic target for controlling hyperpigmentation. Structurally, tyrosinase is a type 3 binuclear copper metalloenzyme, built around six highly conserved histidine residues that coordinate two copper ions within the active site.

Existing inhibitors leave considerable room for improvement. Traditional agents are mostly substrate analogues of L-tyrosine and L-dopa or resorcinol derivatives, and include natural products such as kojic acid, arbutin, resveratrol, polyphenols, flavonoids, stilbenes and lignans. These compounds typically show weak activity and require high concentrations, which raises the risk of skin irritation and, in the case of kojic acid metabolites, liver burden. Many are highly hydrophilic and penetrate skin poorly, and several degrade under light, heat or oxidation. Extraction from natural sources is costly and difficult to standardize. Synthetic second-generation inhibitors, including kojic acid, azole, thiourea, amide, cinnamic acid and benzopentacyclic derivatives, improve activity and stability, but many carry structural safety liabilities, risk of resistance and complex synthetic routes, while their derivation from natural-product scaffolds limits structural novelty.

To break this pattern, the team turned to a de novo molecular generation strategy in which artificial intelligence does not merely screen existing libraries but actively invents new chemical entities. The system is built on the Soft Actor-Critic reinforcement learning algorithm and treats molecular synthesis as a sequential decision-making process. Rather than assembling atoms freely, the model starts from commercially available molecular building blocks and applies established chemical reaction templates through forward reaction prediction, a design choice that guarantees the synthetic accessibility of everything it proposes. In the initial stage, each building block in a predefined library is docked against the tyrosinase crystal structure using AutoDock Vina, and the top 200 fragments by docking score form the starting set.

During the generation phase, each round randomly selects a starting molecule and, guided by the current policy, picks a reaction template to perform a chemical modification. Every product is immediately docked against tyrosinase and assessed for drug-like properties, with the binding affinity feeding a reward function that teaches the model which molecular choices pay off. Each step is logged in a replay buffer, enabling iterative updates of the network parameters through random sampling during training. Generation stops after a maximum of three synthetic steps, when molecular weight exceeds 600 daltons, or when no suitable reaction template can be found. In post-processing, a virtual library of 20,000 generated molecules is filtered through Lipinski’s Rule of Five, ranked by predicted binding affinity, and the top 100 candidates along with their synthetic pathways are submitted to medicinal chemistry experts, who selected roughly 20 molecules for actual synthesis.

Seven generation runs targeting tyrosinase, each yielding the model’s top 100 molecules, produced a pool of 700 candidates from which 17 compounds were synthesized and tested. Ten showed moderate to high inhibition of mushroom tyrosinase, and seven outperformed both alpha-arbutin and beta-arbutin, the clinical reference compounds. The standout was compound V, a piperazine-containing molecule with a monohydroxyphenyl pharmacophore, which inhibited tyrosinase with an IC50 of 18.5 micromoles against L-dopa and 9.6 micromoles against L-tyrosine, already surpassing kojic acid. Molecular docking revealed why: the phenolic hydroxyl group coordinates the catalytic copper ion, while the aromatic ring engages HIS263, ALA286 and VAL283 through pi-stacking, pi-alkyl and pi-sigma interactions.

With compound V in hand, the chemists launched a systematic structure-activity campaign, dividing the scaffold into four modular regions: the aromatic Ar cap, the two linkers, the central piperazine ring, and the phenolic D-ring that chelates copper. Across 34 optimized analogues, clear rules emerged. A monofunctionalized phenyl Ar group, a methylene linker, a vinyl linker and a piperazine core were all favorable, but the decisive change was converting the D-ring to a 2,4-dihydroxyphenyl group. Thirteen compounds in this series, V-22 through V-34, reached nanomolar potency, and compound V-24, which pairs a 4-fluorobenzyl-piperazine cap with a 2,4-dihydroxyphenyl unit, emerged as the most potent inhibitor. In silico property profiling showed V-24 satisfies Lipinski and Veber rules with a high QED of 0.83, strong predicted bioavailability of 87.71 percent and a moderate half-life, supporting its selection as a candidate compound.

Biological validation followed at multiple scales. In B16F10 and A375 melanoma cell lines, both compounds showed no significant cytotoxicity at 100 micromoles and suppressed melanin synthesis in a dose-dependent manner, with V-24 rivaling beta-arbutin in B16F10 cells and clearly outperforming all controls in A375 cells. In zebrafish embryos, a classic whole-organism model for pigmentation, V-24 reduced head melanin signal by 16.32 percent, on par with kojic acid. Most strikingly, in a three-dimensional human skin model incorporating both keratinocytes and melanocytes and subjected to seven days of UVB irradiation, V-24 treatment produced the lightest coloration of any group, with an L-value of 83.38 versus 70.98 for kojic acid at the same concentration. Surface plasmon resonance confirmed direct binding to tyrosinase, and metabolic studies showed the compound is highly stable in human plasma, retaining 89.06 percent after two hours, while being moderately cleared by liver microsomes.

The study demonstrates that pairing an AI de novo generation engine, constrained by reaction templates and rewarded by docking scores, with conventional expert-driven lead optimization can redefine the efficiency of inhibitor discovery, collapsing what is typically a years-long journey from target to nanomolar candidate into a single integrated workflow. The authors suggest this hybrid strategy, in which artificial intelligence proposes structurally novel, synthetically feasible starting points and medicinal chemists refine them through iterative structure-activity analysis, offers a generalizable blueprint not only for anti-pigmentation therapeutics and cosmetics but potentially for drug discovery campaigns against other metalloenzyme targets. All animal experiments were approved by an institutional ethics committee, and the model’s source code and reaction template library have been made publicly available to the research community.

Subject of Research: AI-driven de novo molecular generation and expert-guided optimization of nanomolar tyrosinase inhibitors for treating skin hyperpigmentation

Article Title: Strategy and efficiency-redefined discovery of novel nanomolar tyrosinase inhibitors: AI de novo molecular generation + expert-guided structural optimization

Article References: Sun, Y., Wang, J., Chen, W., Wen, H., Feng, M., Niu, X., Zhi, J., Hu, S., Wang, S., Cai, H., Ju, B., Yang, K., Jiang, X., & Bai, R. (2026). Strategy and efficiency-redefined discovery of novel nanomolar tyrosinase inhibitors: AI de novo molecular generation + expert-guided structural optimization. Journal of Advanced Research, 87, 1079-1104. https://doi.org/10.1016/j.jare.2025.12.041

Image Credits: AI Generated

DOI: 10.1016/j.jare.2025.12.041

Keywords: tyrosinase inhibitors, artificial intelligence, de novo drug design, reinforcement learning, melanin synthesis, skin hyperpigmentation, kojic acid, piperazine derivatives, molecular docking, 3D human skin model, zebrafish assay, medicinal chemistry